Document Detail


Neuro-ophthalmic complications in giant cell arteritis.
MedLine Citation:
PMID:  18606086     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Giant cell arteritis (GCA) is a medical emergency characterized by systemic inflammation and critical ischemia. Neuro-ophthalmic complications occur early, with permanent vision loss in up to one fifth of patients. This mainly results from failure of prompt recognition and treatment. Diagnosis of GCA is often preceded by unrecognized symptoms, including constitutional upset and jaw claudication. Features predictive of permanent visual loss include jaw claudication and temporal artery abnormalities on physical examination. These patients often do not mount high inflammatory responses. Modern imaging techniques show diagnostic promise, and have led to an increased recognition of major artery involvement in GCA. However, temporal artery biopsy remains the gold standard for investigation. Intimal hyperplasia on histologic examination is associated with neuro-ophthalmic complications. The mainstay of therapy remains corticosteroids. Experience using conventional disease-modifying drugs has been mixed, and biologic therapies require further evaluation for their steroid-sparing potential.
Authors:
Frances A Borg; Victoria L J Salter; Bhaskar Dasgupta
Related Documents :
15226966 - Surgical considerations in aortitis. part iii: syphilitic and other forms of aortitis.
16284486 - Panaortitis: diagnosis via fluorodeoxyglucose positron emission tomography.
17724246 - Accuracy and precision of noninvasive temperature measurement in adult intensive care p...
16859596 - Aortic involvement in rheumatic diseases.
9196366 - Hypertension secondary to progressive vascular neurofibromatosis.
10656906 - Mechanical properties of metallic stents: how do these properties influence the choice ...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current allergy and asthma reports     Volume:  8     ISSN:  1534-6315     ISO Abbreviation:  Curr Allergy Asthma Rep     Publication Date:  2008 Jul 
Date Detail:
Created Date:  2008-07-08     Completed Date:  2008-08-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101096440     Medline TA:  Curr Allergy Asthma Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  323-30     Citation Subset:  IM    
Affiliation:
Department of Rheumatology, Southend University Hospital, Prittlewell Chase, Westcliffe-on-Sea, Essex, SS0 0RY, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenal Cortex Hormones / therapeutic use*
Anti-Inflammatory Agents / therapeutic use*
Aspirin / therapeutic use
Cytokines / immunology,  metabolism*
Giant Cell Arteritis / complications*,  diagnosis,  drug therapy,  immunology
Humans
Ischemia / immunology,  physiopathology
Risk Factors
T-Lymphocytes / immunology,  metabolism
Vision Disorders / etiology*,  immunology,  metabolism
Chemical
Reg. No./Substance:
0/Adrenal Cortex Hormones; 0/Anti-Inflammatory Agents; 0/Cytokines; 50-78-2/Aspirin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Stress and atopic dermatitis.
Next Document:  Intraocular inflammation: its causes and investigations.